Intelligent Cavitation-Enhanced Drug Treatment Planning System

Publication ID: 24-11857807_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Cavitation-Enhanced Drug Treatment Planning System,” Published Technical Disclosure No. 24-11857807_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857807_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,807.

Summary of the Inventive Concept

A novel system integrating AI, IoT, blockchain, and simulation-based technology to optimize cavitation-enhanced drug treatment planning, ensuring personalized, secure, and efficient treatment outcomes.

Background and Problem Solved

The original patent disclosed a system for simulating and adjusting cavitation-enhanced drug-treatment procedures prior to execution. However, it lacked the integration of advanced technologies to enhance its capabilities. The new inventive concept addresses this limitation by combining AI, IoT, blockchain, and simulation-based technology to provide a more comprehensive and effective drug treatment planning system.

Detailed Description of the Inventive Concept

The Intelligent Cavitation-Enhanced Drug Treatment Planning System consists of a neural network-based simulation module, a database storing historical treatment data and outcomes, and a recommendation engine for suggesting optimized treatment protocols. The system utilizes AI-driven ultrasound image analysis, IoT-enabled ultrasound devices for real-time monitoring and adjustment, and a blockchain-based decentralized data management system for secure and transparent data storage and access. The system predicts treatment outcomes, provides personalized treatment planning, and enables real-time monitoring and adjustment of cavitation-enhanced drug-treatment procedures.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, and blockchain technologies with simulation-based drug treatment planning, providing a novel and non-obvious solution that enhances the capabilities of the original patent. The inventive step lies in the synergistic combination of these technologies to create a more powerful and effective drug treatment planning system.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different AI algorithms, varying IoT device configurations, or alternative blockchain architectures. Additionally, the system could be adapted for use in other medical applications, such as gene therapy or cancer treatment.

Potential Commercial Applications and Market

The Intelligent Cavitation-Enhanced Drug Treatment Planning System has significant commercial potential in the healthcare industry, particularly in the fields of neurology, oncology, and gene therapy. The system's ability to provide personalized, secure, and efficient treatment outcomes makes it an attractive solution for pharmaceutical companies, hospitals, and research institutions.

Field of Art

Medical imaging, biomedical engineering, and computational systems for drug treatment planning, with expertise in ultrasound-based medical interventions, simulation technologies, and advanced computational methods for medical treatment optimization

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in biomedical engineering, computer science, or medical physics, possessing expertise in medical imaging, AI/machine learning, ultrasound technologies, and computational simulation techniques for medical treatments

Obviousness Rationale

A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies with the existing simulation-based drug treatment planning system represents a predictable extension of known computational techniques. The source patent's core method of simulating and adjusting ultrasound-based drug treatments provides a clear foundation for enhancing the system with advanced computational technologies. The proposed variations represent logical technological improvements that would be apparent to a skilled practitioner seeking to optimize medical treatment planning systems.

Obvious Combinations & Variations

Source Patent Element
Processor configured to predict degree of tissue disruption as a function of time
PTD Variation
Neural network-based simulation module for predicting treatment outcomes using AI algorithms
Obviousness Reasoning
Extending predictive computational methods with machine learning represents a known technique for improving predictive accuracy in medical simulation systems, with predictable results of enhanced treatment planning
Source Patent Element
Sonication parameter adjustment based on predicted tissue disruption
PTD Variation
Real-time monitoring and adjustment using IoT-enabled ultrasound devices
Obviousness Reasoning
Implementing continuous monitoring and adaptive treatment protocols is a natural technological progression for improving medical intervention systems, representing an obvious design optimization
Source Patent Element
System for comparing predicted tissue disruption against target objectives
PTD Variation
Blockchain-based decentralized data management for storing and analyzing treatment outcomes
Obviousness Reasoning
Utilizing distributed data storage and analysis technologies is a predictable solution for improving data management in medical treatment systems, with clear technological benefits in transparency and accessibility
Source Patent Element
Processor configured to alter treatment protocol based on predicted outcomes
PTD Variation
Machine learning-based predictive model trained on historical treatment data and updated in real-time
Obviousness Reasoning
Implementing adaptive learning systems to improve treatment protocols represents a standard technological approach for enhancing medical simulation and intervention technologies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857807 for simulation-based drug treatment planning, the present publication demonstrates that the integration of AI, IoT, and blockchain technologies into ultrasound-based medical treatment systems would be obvious to a person having ordinary skill in the art, thereby rendering potential claims to such technological combinations anticipated and non-patentable under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,807
TitleSimulation-based drug treatment planning
Assignee(s)INSIGHTEC, LTD.